Clear Street Markets LLC Dexcom Inc Transaction History

Clear Street Markets LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 26, 2024	BUY	$110.31 - $140.45 $5,846 - $7,443	53 New	53 $6,000
Q4 2023 Feb 13, 2024	SELL	$75.49 - $124.16 $981 - $1,614	-13 Reduced 29.55%	31 $4,000
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $7,487 - $11,999	-87 Reduced 66.41%	44 $4,000
Q2 2023 Aug 14, 2023	BUY	$112.47 - $130.98 $14,733 - $17,158	131 New	131 $17,000
Q4 2022 Feb 13, 2023	SELL	$84.98 - $122.67 $130,954 - $189,034	-1,541 Reduced 99.94%	1 $0
Q3 2022 Nov 02, 2022	BUY	$76.35 - $94.18 $117,731 - $145,225	1,542 New	1,542 $124,000
Q2 2022 Aug 02, 2022	SELL	$67.99 - $132.89 $29,915 - $58,471	-440 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$94.08 - $130.2 $41,395 - $57,287	440 New	440 $225,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Clear Street Markets LLC, based on Form 13F filings with the SEC.

Stay updated on Clear Street Markets LLC with notifications on news.